Ensuring the safe use of genomic medicine in children

Area of Science:

• Pediatric Genomics
• Clinical Genetics
• Translational Medicine

Background:

• Current clinical guidelines advocate genetic testing in children only for immediate benefits.
• Genome risk profiling offers long-term health benefits, not immediate clinical utility.
• Children at higher genetic risk benefit most from early interventions.

Purpose of the Study:

• To advocate for the use of genome risk profiling in identifying at-risk children.
• To propose a reevaluation of current genetic testing practices for pediatric populations.
• To highlight the need for a nuanced approach to integrating genomic risk profiling in pediatric care.

Main Methods:

• This commentary reviews current practices and proposes a shift in approach.
• It emphasizes the importance of a tailored delivery and follow-up strategy.
• Key elements for successful implementation are discussed.

Main Results:

• Genome risk profiling can identify children who would benefit from early interventions.
• The benefits of genome risk profiling are primarily long-term, necessitating a practice shift.
• A nuanced approach is required for clinical integration.

Conclusions:

• Genomic risk profiling holds significant potential for proactive pediatric healthcare.
• Clinical guidelines may need revision to incorporate long-term benefit genetic testing.
• Effective implementation requires careful consideration of counseling, consent, communication, and follow-up.